help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tseng, C.-C.
Right arrow Articles by Zhang, X.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tseng, C.-C.
Right arrow Articles by Zhang, X.-Y.
Endocrinology Vol. 141, No. 3 947-952
Copyright © 2000 by The Endocrine Society


ARTICLES

Role of G Protein-Coupled Receptor Kinases in Glucose-Dependent Insulinotropic Polypeptide Receptor Signaling1

Chi-Chuan Tseng and Xiao-Ying Zhang

Section of Gastroenterology, Boston Veterans Administration Medical Center, and Boston University School of Medicine, Boston, Massachusetts 02118

Address all correspondence and requests for reprints to: Chi-Chuan Tseng, M.D., Ph.D., Section of Gastroenterology, Boston University School of Medicine, Boston, Massachusetts 02118.

The glucose-dependent insulinotropic polypeptide receptor (GIPR) is a member of class II G protein-coupled receptors. Recent studies have suggested that desensitization of the GIPR might contribute to impaired insulin secretion in type II diabetic patients, but the molecular mechanisms of GIPR signal termination are unknown. Using HEK L293 cells stably transfected with GIPR complementary DNA (L293-GIPR), the mechanisms of GIPR desensitization were investigated. GIP dose dependently increased intracellular cAMP levels in L293-GIPR cells, but this response was abolished (65%) by cotransfection with G protein-coupled receptor kinase 2 (GRK2), but not with GRK5 or GRK6. ß-Arrestin-1 transfection also induced a significantly decrease in GIP-stimulated cAMP production, and this effect was greater with cotransfection of both GRK2 and ß-arrestin-1 than with either alone. In ßTC3 cells, expression of GRK2 or ß-arrestin-1 attenuated GIP-induced insulin release and cAMP production, whereas glucose-stimulated insulin secretion was not affected. GRK2 and ß-arrestin-1 messenger RNAs were identified by Northern blot analysis to be expressed endogenously in ßTC3 and L293 cells. Overexpression of GRK2 enhanced agonist-induced GIPR phosphorylation, but receptor endocytosis was not affected by cotransfection with GRKs or ß-arrestin-1. These results suggest a potential role for GRK2/ß-arrestin-1 system in modulating GIP-mediated insulin secretion in pancreatic islet cells. Furthermore, GRK-mediated receptor phosphorylation is not required for endocytosis of the GIPR.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E. Cipolletta, A. Campanile, G. Santulli, E. Sanzari, D. Leosco, P. Campiglia, B. Trimarco, and G. Iaccarino
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance
Cardiovasc Res, August 11, 2009; (2009) cvp252v2.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Jiang, P. Yang, and L. Ma
Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development
PNAS, June 23, 2009; 106(25): 10183 - 10188.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. J. Lu, Q. Yang, W. Sun, S. C. Woods, D. D'Alessio, and P. Tso
Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose
Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1130 - G1138.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. M. Swords, S. Aylwin, L. Perry, J. Arola, A. B. Grossman, J. P. Monson, and A. J. L. Clark
The Aberrant Expression of the Gastric Inhibitory Polypeptide (GIP) Receptor in Adrenal Hyperplasia: Does Chronic Adrenocorticotropin Exposure Stimulate Up-Regulation of GIP Receptors in Cushing's Disease?
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3009 - 3016.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Jorgensen, L. Martini, T. W. Schwartz, and C. E. Elling
Characterization of Glucagon-Like Peptide-1 Receptor {beta}-Arrestin 2 Interaction: A High-Affinity Receptor Phenotype
Mol. Endocrinol., March 1, 2005; 19(3): 812 - 823.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Chen, R. Gaudreau, C. Le Gouill, M. Rola-Pleszczynski, and J. Stankova
Agonist-Induced Internalization of Leukotriene B4 Receptor 1 Requires G-Protein-Coupled Receptor Kinase 2 but Not Arrestins
Mol. Pharmacol., September 1, 2004; 66(3): 377 - 386.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. A. Hinke, K. Hellemans, and F. C. Schuit
Plasticity of the {beta} cell insulin secretory competence: preparing the pancreatic {beta} cell for the next meal
J. Physiol., July 15, 2004; 558(2): 369 - 380.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society